GLP-1 receptor agonist or SGLT2 inhibitor prescribing became more common for people with type 1 diabetes in recent years, a nationwide cross-sectional analysis found. From 2010 to 2023, the percentage ...

Patients with type 1 diabetes (T1D) who have risk factors such as obesity and hypertension can develop insulin resistance over time, a characteristic typically associated with type 2 diabetes (T2D).

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% who ...

Food is fuel for the body. In most people, islet cells in the pancreas secrete insulin that converts food into usable energy. But in those with Type 1 diabetes, the immune system attacks and destroys ...

There’s a cliché in the type 1 diabetes community that a cure has been “five years away” for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of ...

A new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type 1 diabetes (often called juvenile diabetes) compared to those with Type 2 diabetes. The ...

Ischemic stroke risk was associated with higher A1C levels among individuals with type 1 and type 2 diabetes. Compared with the general population, individuals with type 1 diabetes (T1D) had a higher ...

A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...